Short-term efficacy and long-term compliance/treatment failure of the α1 blocker naftopidil for patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia

By Masumori Naoya   Hashimoto Jiro   Itoh Naoki   Tsukamoto Taiji   Group The Sapporo Medical University Naftopidil Study  

Scandinavian Journal of Urology and Nephrology, Vol. 41, Iss. 5, 2007-01 ,pp. : 422-429

Informa Healthcare

Access to resources Recommend Favorite

Naftopidil and propiverine hydrochloride for treatment of male lower urinary tract symptoms suggestive of benign prostatic hyperplasia and concomitant overactive bladder: A prospective randomized controlled study

By Yokoyama Teruhiko   Uematsu Katsutoshi   Watanabe Toyohiko   Sasaki Katsumi   Kumon Hiromi   Nagai Atsushi  

Scandinavian Journal of Urology and Nephrology, Vol. 43, Iss. 4, 2009-09 ,pp. : 307-314

Informa Healthcare

Access to resources Recommend Favorite

Baseline prostate specific antigen does not affect the efficacy of tamsulosin in patients with lower urinary tract symptoms/benign prostatic hyperplasia

By Speakman M.J.   Snijder J.R.   Anthonijs G.L.   Doyle C.A.  

European Urology Supplements, Vol. 2, Iss. 1, 2003-02 ,pp. : 159-159

Elsevier

Access to resources Recommend Favorite

Tamsulosin is effective in patients with lower urinary tract symptoms/benign prostatic hyperplasia, irrespective of prostate size

By Speakman M.J.   Snijder J.R.   Anthonijs G.L.   Doyle C.A.   Carter A.  

European Urology Supplements, Vol. 2, Iss. 1, 2003-02 ,pp. : 75-75

Elsevier

Access to resources Recommend Favorite

The role of phytotherapy in treating lower urinary tract symptoms and benign prostatic hyperplasia

By Dreikorn Kurt  

World Journal of Urology, Vol. 19, Iss. 6, 2002-04 ,pp. : 426-435

Springer Publishing Company

Access to resources Recommend Favorite